Riskpilot← Back to searchSign inGet full accessSPESIALISTKLINIKKENE AS
ASActiveOrg 918711449Lysaker Torg 5, 1366 LysakerMedical specialists activities · NACE 8622Est. 20170 employees
Revenue 2024
NOK 0
EBITDA margin
—
-111% vs 2023
Equity ratio
50.7%
Financial strength
Net profit 2024
NOK -514
-101% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -145K | -111% |
| Net profit | NOK -514 | -101% |
| Total assets | NOK 9,1M | +7% |
| Equity | NOK 4,6M | +0% |
| Employees | 0 | — |
Legal name
SPESIALISTKLINIKKENE AS
Org number
918711449
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. mars 2017
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Å drive spesialistlegevirksomhet samt delta, eie og drive andre klinikker innenfor helsesegmentet.
Address
Lysaker Torg 5, 1366 Lysaker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −28 | −36 | −49 | −69 | −145 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −28 | −36 | −49 | −69 | −145 |
| Net financials | 4 999 | 1 640 | 2 000 | 120 | 144 |
| Profit before tax | 4 971 | 1 604 | 1 951 | 51 | −1 |
| Tax | −6 | 23 | −11 | 11 | −0 |
| Net profit | 4 977 | 1 581 | 1 962 | 40 | −1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 836 | 5 629 | 7 284 | 8 567 | 9 140 |
| Equity | 4 047 | 4 128 | 4 590 | 4 630 | 4 629 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 789 | 1 501 | 2 694 | 3 937 | 4 510 |
| Total debt | 3 789 | 1 501 | 2 694 | 3 937 | 4 510 |
EBITDA margin
-14465800.0%
This company
15.8%
Market median
-91555796% vs market
20202024
Equity ratio
50.7%
This company
38.2%
Market median
+33% vs market
20202024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
-51400.0%
This company
8.1%
Market median
-634668% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FM Chief Executive Officer | Chief Executive Officer | 2017 |
| Former (1) | ||
HK Deputy Member | Deputy Member | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (2) | ||
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2018 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 90% | 90% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Maqsood Holding As
SPESIALISTKLINIKKENE AS Board members of SPESIALISTKLINIKKENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halima Khawaja Maqsood | Deputy Member | 0 companies |
| Farooq Maqsood | Chief Executive Officer | 0 companies |
| Birgir Andri Briem | Board of Directors | 0 companies |
| Stein Helge Glad Nordahl | Board of Directors | 0 companies |
| Kent Jensen | Board of Directors | 0 companies |
| Gard Filip Gjerdalen | Chairman | 0 companies |
| Ralph Herbert Dollner | Board of Directors | 0 companies |